PEOPLE - Changes at VenPro:
This article was originally published in Clinica
Executive Summary
Rob Michiels has resigned from his dual position as president and chief operating officer of Interventional Technologies and managing director of the US cardiovascular device company's European subsidiary to join the California-based life sciences company VenPro. Other organisational changes within the company include Dr William Crawford retiring in August as vice-president of medical and regulatory affairs; and the promotion of Michael Klicpera to vice-president of legal and regulatory affairs, Dolf Meewis to vice-president of international sales and marketing and Ed Pannek to managing director of Interventional Technologies Europe.